“Lipoprotein(a) as an Unmodifiable Risk Marker in a Modifiable Risk World: Testing, Interpretation and Communication” (2021) Journal of Heart and Cardiovascular Science, 2(1), pp. 14–19. doi:10.5281/zenodo.22305492.